Oncology Central

The next generation of smart gold nanobeacons: nanotheranostics is ready for prime time


The most elementary principle of theranostics (diagnostics and therapy) has been in practice for decades. Since the 1940s, we have been able to image (diagnostics) and treat (therapy) thyroid cancers using radioiodine (also known as the radioisotope Iodine-131) [1]. More recently, advances in molecular biology and medicine together with the cumulative knowledge at the intersection of biomaterials science and innovative imaging has provided a wealth of functional biomarkers for a range of diseases.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.